EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 40 (Novembre 2024) Hors série n° 1 Med Sci (Paris), 40 (2024) 40-44 References
Free Access
Issue
Med Sci (Paris)
Volume 40, Novembre 2024
Les Cahiers de Myologie
Page(s) 40 - 44
Section Prix SFM
DOI https://doi.org/10.1051/medsci/2024129
Published online 18 November 2024
  1. Johnson NE, Butterfield RJ, Mayne K, et al. Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program. Neurology 2021 ; 96 : e1045–e1053. [PubMed] [Google Scholar]
  2. Overend G, Légaré C, Mathieu J, et al. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes. Hum Mol Genet 2019 ; 28 : 2245–2254. [CrossRef] [PubMed] [Google Scholar]
  3. De Antonio M, Dogan C, Hamroun D, et al. Unravelling the myotonic dystrophy type 1 clinical spectrum: a systematic registry-based study with implications for disease classification. Rev Neurol (Paris) 2016 ; 172 : 572–580. [CrossRef] [PubMed] [Google Scholar]
  4. Ravel-Chapuis A, Duchesne E, Jasmin BJ. Pharmacological and exercise-induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients. J Physiol 2022 ; 600 : 3249–3264. [CrossRef] [PubMed] [Google Scholar]
  5. Dahlqvist JR, Ørngreen MC, Witting N, Vissing J. Endocrine function over time in patients with myotonic dystrophy type 1. Eur J Neurol 2015 ; 22 : 116–122. [CrossRef] [PubMed] [Google Scholar]
  6. Severinsen MCK, Pedersen BK. Muscle–Organ Crosstalk: The Emerging Roles of Myokines. Endocr Rev 2020 ; 41 : 594–609. [CrossRef] [PubMed] [Google Scholar]
  7. Ozimski LL, Sabater-Arcis M, Bargiela A, Artero R. The hallmarks of myotonic dystrophy type 1 muscle dysfunction. Biol Rev Camb Philos Soc 2021 ; 96 : 716–730. [CrossRef] [PubMed] [Google Scholar]
  8. Grande V, Hathazi D, O’Connor E, et al. Dysregulation of GSK3β-target proteins in skin fibroblasts of Myotonic Dystrophy Type 1 (DM1) patients. J Neuromuscul Dis 2021 ; 8 : 603–619. [CrossRef] [PubMed] [Google Scholar]
  9. Brockhoff M, Rion N, Chojnowska K, et al. Targeting deregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I. J Clin Invest 2017 ; 127 : 549–563. [CrossRef] [PubMed] [Google Scholar]
  10. Ravel-Chapuis A, Al-Rewashdy A, Bélanger G, et al. Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles. Hum Mol Genet 2018 ; 27 : 3361–3376. [CrossRef] [PubMed] [Google Scholar]
  11. Steinberg GR, Hardie DG. New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol 2023 ; 24 : 255–272. [CrossRef] [PubMed] [Google Scholar]
  12. Theret M, Gsaier L, Schaffer B, et al. AMPKα1-LDH pathway regulates muscle stem cell self-renewal by controlling metabolic homeostasis. EMBO J 2017 ; 36 : 1946–1962. [CrossRef] [PubMed] [Google Scholar]
  13. Kneppers A, Ben Larbi S, Theret M, et al. AMPKα2 is a skeletal muscle stem cell intrinsic regulator of myonuclear accretion. iScience 2023 ; 26 : 108343. [CrossRef] [PubMed] [Google Scholar]
  14. Misquitta NS, Ravel-Chapuis A, Jasmin BJ. Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner. Hum Mol Genet 2023 ; 32 : 551–566. [CrossRef] [PubMed] [Google Scholar]
  15. Todorow V, Hintze S, Kerr ARW, et al. Transcriptome analysis in a primary human muscle cell differentiation model for myotonic dystrophy type 1. Int J Mol Sci 2021 ; 22 : 8607. [CrossRef] [PubMed] [Google Scholar]
  16. Mikhail AI, Manta A, Ng SY, et al. A single dose of exercise stimulates skeletal muscle mitochondrial plasticity in myotonic dystrophy type 1. Acta Physiol (Oxf) 2023 ; 237 (4) : e13943. [CrossRef] [PubMed] [Google Scholar]
  17. García-Puga M, Saenz-Antoñanzas A, Fernández-Torrón R, et al. Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin. Aging (Albany NY) 2020 ; 12 : 6260–6275. [CrossRef] [PubMed] [Google Scholar]
  18. Di Leo V, Lawless C, Roussel MP, et al. Resistance exercise training rescues mitochondrial dysfunction in skeletal muscle of patients with myotonic dystrophy type 1. J Neuromuscul Dis 2023 ; 10 : 1111–1126. [CrossRef] [PubMed] [Google Scholar]
  19. Zhao H, Li T, Wang K, et al. AMPK-mediated activation of MCU stimulates mitochondrial Ca2+ entry to promote mitotic progression. Nat Cell Biol 2019 ; 21 : 476–486. [CrossRef] [PubMed] [Google Scholar]
  20. Renna LV, Bosè F, Brigonzi E, et al. Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies. PLoS One 2019 ; 14 : e0214254. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.